Financials Skin n Skin Co., Ltd.

Equities

A159910

KR7159910009

Commodity Chemicals

End-of-day quote Korea S.E. 23:00:00 26/05/2024 BST 5-day change 1st Jan Change
807 KRW +2.80% Intraday chart for Skin n Skin Co., Ltd. -0.98% +22.27%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 63,395 42,739 35,971 74,678 86,912 23,224
Enterprise Value (EV) 1 52,652 30,621 32,645 49,511 75,117 21,104
P/E ratio -4.46 x -5.94 x -1.28 x 54.6 x -8.52 x -2.46 x
Yield - - - - - -
Capitalization / Revenue 2 x 2.04 x 1.37 x 2.7 x 4.06 x 1.67 x
EV / Revenue 1.66 x 1.46 x 1.24 x 1.79 x 3.51 x 1.52 x
EV / EBITDA -21.5 x -5.66 x -1.73 x 17.8 x -15.6 x -3.35 x
EV / FCF -9.02 x -5.13 x -1.89 x -127 x -13.9 x -15.9 x
FCF Yield -11.1% -19.5% -52.9% -0.79% -7.19% -6.3%
Price to Book 1.8 x 1.13 x 3.08 x 2.46 x 3.16 x 1.29 x
Nbr of stocks (in thousands) 10,619 13,232 13,677 28,395 35,187 35,187
Reference price 2 5,970 3,230 2,630 2,630 2,470 660.0
Announcement Date 11/04/19 30/03/20 23/03/21 23/03/22 07/04/23 21/03/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 31,664 20,974 26,348 27,612 21,406 13,924
EBITDA 1 -2,451 -5,412 -18,858 2,783 -4,812 -6,299
EBIT 1 -4,752 -7,256 -20,630 1,907 -6,281 -6,840
Operating Margin -15.01% -34.6% -78.3% 6.9% -29.34% -49.12%
Earnings before Tax (EBT) 1 -12,874 -8,131 -27,856 1,682 -10,096 -7,217
Net income 1 -13,059 -6,289 -27,852 1,213 -10,045 -9,438
Net margin -41.24% -29.99% -105.71% 4.39% -46.92% -67.78%
EPS 2 -1,339 -543.7 -2,060 48.19 -290.0 -268.2
Free Cash Flow 1 -5,838 -5,972 -17,278 -390.9 -5,399 -1,330
FCF margin -18.44% -28.47% -65.58% -1.42% -25.22% -9.56%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 11/04/19 30/03/20 23/03/21 23/03/22 07/04/23 21/03/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 10,742 12,118 3,326 25,167 11,796 2,120
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -5,838 -5,972 -17,278 -391 -5,399 -1,330
ROE (net income / shareholders' equity) -42.1% -21.4% -113% 6.86% -31.1% -31.7%
ROA (Net income/ Total Assets) -5.52% -8.31% -36.8% 3.78% -9.81% -13.7%
Assets 1 236,781 75,699 75,606 32,064 102,395 69,086
Book Value Per Share 2 3,308 2,871 853.0 1,069 780.0 512.0
Cash Flow per Share 2 1,719 1,518 446.0 787.0 411.0 189.0
Capex 1 1,272 2,131 8,642 303 411 651
Capex / Sales 4.02% 10.16% 32.8% 1.1% 1.92% 4.67%
Announcement Date 11/04/19 30/03/20 23/03/21 23/03/22 07/04/23 21/03/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. A159910 Stock
  4. Financials Skin n Skin Co., Ltd.